Name: EVOTEC SE (EVT) Stock
Brand: EVOTEC SE
Rating: 3.5 (3 reviews)

Question 1

Can you describe the business of EVOTEC SE?

Accepted Answer

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. The company is headquartered in Hamburg, Hamburg and currently employs 4,788 full-time employees.  The firm is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Question 2

What is the current price of EVT stock?

Accepted Answer

The current stock price of EVT.DE is 5.45 EUR. The price increased by 0.26% in the last trading session.

Question 3

Does EVOTEC SE pay dividends?

Accepted Answer

EVT.DE does not pay a dividend.

Question 4

What is the ChartMill technical and fundamental rating of EVT stock?

Accepted Answer

EVT.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

Question 5

Would investing in EVOTEC SE be a good decision?

Accepted Answer

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EVT.DE.

Question 6

Can you provide the growth outlook for EVOTEC SE?

Accepted Answer

The Revenue of EVOTEC SE (EVT.DE) is expected  to decline by -2.93% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.

Question 7

What is the market capitalization of EVT stock?

Accepted Answer

EVOTEC SE (EVT.DE) has a market capitalization of 1.94B EUR. This makes EVT.DE a Small Cap stock.

EVOTEC SE (EVT.DE) Stock Price, Forecast & Analysis

EVT.DE Latest News, Press Relases and Analysis